Skip to main content

Age-related changes in human sperm DNA integrity

Age-related changes in human sperm DNA integrity

Abstract

Abnormal standard semen characteristics and reduced sperm chromatin maturity can appear with increasing male age. However, the influence of paternal age on semen parameters is still controversial. Therefore, this study was designed to estimate the influence of paternal age not only on conventional semen characteristics but also on sperm DNA integrity. This research was carried out on ejaculated sperm cells obtained from men (n = 1124) aged ≥40 y and <40 y. Our data revealed a decreased semen volume and an increased percentage of DFI (sperm DNA fragmentation index) in older men compared to younger men in the entire study cohort, in men with normozoospermia and in men with abnormal semen parameters. Moreover, there was a higher incidence of sperm DNA damage (>10% DFI, low fertility potential) in the groups of men aged ≥40 y than in the groups of men aged <40 y. Older men had over twice the odds ratio for high sperm DNA damage as younger men. Our findings suggest a detrimental effect of advanced paternal age on sperm chromatin integrity. The data show that the evaluation of sperm DNA has greater clinical utility than standard semen analysis in case of male fertility potential assessment.

Introduction

Infertility has become a worldwide problem, affecting up to 20% of couples trying to conceive [12]. In this context, a few important facts should be emphasized: 1) male factors (coexisting with female factors) contribute to infertility in up to 20–70% of cases, and one-third of these cases are due to male factors alone [13]; 2) an actual decline in semen quality over the past decades has been observed globally [4]; and 3) paternal age is rising, as an increasing number of men are decide to became a father at an older age [56].

It is known that the risk of poor reproductive outcomes can increase with a male age of >40 or even >35 y, commonly classified as advanced age. Age-dependent changes in male organism (e.g. vascular sufficiency, increase in incidence of systemic diseases and infections, disorders of histological structure of testes, decreased levels of sex hormones, oxidative stress, de novo mutations) are deleterious and the consequences of advanced paternal age include a prolonged waiting time to pregnancy, delayed embryo development in in vitro conditions, an increased incidence of embryo implantation failure and abortions, pregnancy problems and live birth outcome [79] (Figure 1). In addition, advanced paternal age also seems to affect children's health. There is a positive correlation between paternal age and the incidence of mental deprivation of offspring, such as those associated with the autism spectrum and diseases such as schizophrenia, especially when the paternal age is ≥40–50 y [1013]. Furthermore, the frequency of genetic disorders, such as Klinefelter syndrome [14]; Down syndrome, when mother age is >35 y [15]; and autosomal dominant diseases such as Marfan syndrome (men >40 y), Pfeiffer and Crouzon syndrome (men >50 y), Apert syndrome (men >37 y), achondroplasia and neurofibromatosis type 1 rises in children of fathers >40 y. Unfortunately, the risk of central nervous system and breast cancers as well as leukaemia is growing [12]. More often, children with heart defects (e.g., ventricular septal defects, atrial septal defects, large vessel transposition), neural tube defects, anencephaly and tracheo-oesophageal fistula have been born to men >35, 40, and 45 y of age [13] (Figure 1https://www.aging-us.com/article/102120/text


When general population mention today’s medicine, precision plays one of the most significant roles and people’s lives are literally dependent on it. Likewise, any researches related to medicine are required to comply with the top standards. The challenge nowadays is that any recommendations of researches can be shared online and used as a reference without being adequately verified and approved. Mikhail (Misha) Blagosklonny of Oncotarget clearly understood this issue and tried to come up with an alternative solution. That’s how a weekly oncology-focused research journal called “Oncotarget” has been founded back in 2010. The main principle of this journal is based on Altmetric scores that are used as a quality measure. That allows both readers and authors to quality-check publications with Altmetric Article Reports that provide “real-time feedback containing data summary related to a particular publication.” Oncotarget website provides a full publications list with corresponding scores higher than 100 as well as reports mentioned above. Mikhail (Misha) Blagosklonny proud to share his new approach and hopes it creates the required assistance to anybody, who has interest in oncology.
“A diagnostic autoantibody signature for primary cutaneous melanoma” has the Altmetric score of 594. This study was released back in 2018 by Oncotarget and written by various experts from Hollywood Private Hospital, Edith Cowan University, Dermatology Specialist Group, St. John of God Hospital and The University of Western Australia. The introduction of the study discusses “recent data shows that Australians are four times more likely to develop a cancer of the skin than any other type of cancer”, and provides an insight on melanoma that “is curable by surgical excision in the majority of cases, if detected at an early stage.”
The article has got an Altmetric score of 594. Mikhail (Misha) Blagosklonny realizes that most of readers are willing to understand the very meaning of it. Based on the Altmetric website, the score indicates “how many people have been exposed to and engaged with a scholarly output.” Likewise, the article about melanoma, was utilized for citations in different news articles 69 times. In addition, it was quoted in 2 online blogs, as well as 25 Tweets on Twitter and 1 Facebook post. FOX23 of Tulsa, Oklahoma has headlined their news on July 20, 2018 as “New blood test could detect skin cancer early”, using the main content of Australia study 
Another Oncotarget’s study with a top score of 476, is “Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moon-shot,”. This research has appeared in 60 news stories, 1 online blog post and 6 Twitter posts. The majority of public may have seen a concise overview only, however those who visit Mikhail (Misha) Blagosklonny at Oncotarget, do receive helpful scientific facts. Oncotarget is glad to have the chance to share with online viewers this highly appreciated and top-quality information, that is trustworthy and reliable.

Comments

Popular posts from this blog

Membrane lipids in invadopodia and podosomes: Key structures for cancer invasion and metastasis

Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential

Zoya N. Demidenko Business Profile